Author

H. Acloque

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Bennaceur-Griscelli· 2 shared A. G. Turhan· 1 shared C. Auriau· 1 shared C. Desterke· 1 shared E. Balducci· 1 shared E. Hadadi· 1 shared G. Duvallet· 1 shared G. Telliam· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Bennaceur-Griscelli

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Modeling Global Genomic Instability in Chronic Myeloid Leukemia (CML) using patient-derived induced pluripotent stem cells (iPSC)

G. Telliam, C. Desterke, J. Imeri, R. Mkacher, N. Oudrhiri, E. Balducci, M. Arnoux, H. Acloque, A. Bennaceur-Griscelli, A. G. Turhan

This study uses patient-derived iPSCs with in vitro mutagenesis to model genomic instability in CML, identifying aberrations linked to blast crisis progression.

Cancers · May 3, 2023Peer-reviewedCancer Biology

Chronic circadian disruption modulates breast cancer cell stemness and their immune microenvironment to drive metastasis in mice

E. Hadadi, W. Taylor, X. Li, Y. Aslan, M. Vilotte, J. Riviere, G. Duvallet, C. Auriau, S. Dulong, I. Raymond Letron, S. Provot, A. Bennaceur-Griscelli, H. Acloque

This study shows chronic circadian disruption in mice increases breast cancer metastasis by enhancing stemness and creating an immunosuppressive microenvironment, which can be reversed by a CXCR2 inhibitor.

bioRxiv · Sep 26, 2019Cancer Biology